Translating Visual Short-Term Memory Binding Tasks to Clinical Practice: From Theory to Practice.

Ivanna M Pavisic,Aida Suarez-Gonzalez,Yoni Pertzov

doi:10.3389/fneur.2020.00458

Abstract

Translating Visual Short-Term Memory Binding Tasks to Clinical Practice: From Theory to Practice.

Highlights

Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia, accounting for 2/3 of all dementia cases and currently recognized as a global public health challenge
Crucial to clinical practice is the transition from (a) the initial confirmation of association with the outcome of interest (e.g., visual shortterm memory (VSTM) binding impairment is associated with a diagnosis of AD) to (b) acquiring sensitivity to a treatment or an intervention (e.g., VSTM binding deficits decline in response to a therapy) and (c) showing a “meaningful” change in patient behavior [41]
The recent Food and Drug Administration guidelines suggest that biomarkers alone will not be sufficient as surrogate outcomes to show effectiveness of treatment [44]

Summary

Introduction

Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia, accounting for 2/3 of all dementia cases and currently recognized as a global public health challenge. One important line of AD research in the last decade has provided evidence that the ability to bind object features together in short-term memory (STM) is affected in AD even at asymptomatic stages [3, 4]. STM binding is a cognitive function known to support the integration of features necessary to maintain a coherent representation of an object in immediate memory.

Results

Conclusion